1-HydroxyPGE1 reduces infarction volume in mouse transient cerebral ischemia

European Journal of Neuroscience

Volumn 23, Issue 1, 2006, Pages 35-42

  Ahmad, Muzamil ^a   Saleem, Sofiyan ^a   Zhuang, Hean ^a   Ahmad, Abdullah Shafique ^a   Echeverria, Valentina ^a   Sapirstein, Adam ^a   Doré, Sylvain ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Agonist; EP receptors; Neuroprotection; PGE2; Prostaglandins; Stroke

Indexed keywords

1 HYDROXYPROSTAGLANDIN E1; CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; THREONINE; TYROSINE; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT; PROSTAGLANDIN E1; PROSTAGLANDIN EP3 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN NERVE CELL; CONTROLLED STUDY; CORE TEMPERATURE; DRUG ACTIVITY; DRUG EXPOSURE; DRUG MECHANISM; DRUG MEGADOSE; EMBRYO; ENZYME PHOSPHORYLATION; MALE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL CULTURE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSIENT ISCHEMIC ATTACK; ANALYSIS OF VARIANCE; ANIMAL; BLOOD GAS ANALYSIS; BLOOD PRESSURE; BODY TEMPERATURE; BRAIN INFARCTION; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; METHODOLOGY; NEUROLOGIC EXAMINATION; PATHOLOGY; WESTERN BLOTTING;

ALPROSTADIL; ANALYSIS OF VARIANCE; ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; BLOTTING, WESTERN; BODY TEMPERATURE; BRAIN INFARCTION; CELLS, CULTURED; CYCLIC AMP; DISEASE MODELS, ANIMAL; EMBRYO; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; MICE, INBRED C57BL; NEUROLOGIC EXAMINATION; NEUROPROTECTIVE AGENTS; RECEPTORS, PROSTAGLANDIN E;

EID: 33644955960     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.04540.x     Document Type: Article

References (47)

1. Adams JP. Sweatt JD. 2002 Molecular psychology: roles for the ERK MAP kinase cascade in memory AnnuRevPharmacolToxicol 42 135 163
2. Bonni A. Brunet A. West AE. Datta SR. Takasu MA. Greenberg ME. 1999 Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms Science 286 1358 1362
3. Boucher MJ. Morisset J. Vachon PH. Reed JC. Laine J. Rivard N. 2000 MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells JCell Biochem 79 355 369
4. Brunet A. Datta SR. Greenberg ME. 2001 Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway CurrOpinNeurobiol 11 297 305
5. Chiu AE. Lane AT. Kimball AB. 2002 Diffuse morbilliform eruption after consumption of ginkgo biloba supplement JAmAcadDermatol 46 145 146
6. Crutchley DJ. Solomon DE. Conanan LB. 1992 Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism ArteriosclerThromb 12 664 670
7. Davis RJ. Murdoch CE. Ali M. Purbrick S. Ravid R. Baxter GS. Tilford N. Sheldrick RL. Clark KL. Coleman RA. 2004 EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries BrJPharmacol 141 580 585
8. De Simoni MG. Rossi E. Storini C. Pizzimenti S. Echart C. Bergamaschini L. 2004 The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q AmJPathol 164 1857 1863
9. Doré S. Kar S. Zheng WH. Quirion R. 2000 Rediscovering good old friend IGF-I in the new millenium: possible usefulness in Alzheimer's disease and stroke PharmActa Helv 74 273 280
10. Doré S. Otsuka T. Mito T. Sugo N. Hand T. Wu L. Hurn PD. Traystman RJ. Andreasson K. 2003 Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction AnnNeurol 54 155 162
11. Ghersa P. Hooft van Huijsduijnen R. Whelan J. Cambet Y. Pescini R. DeLamarter JF. 1994 Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway JBiolChem 269 29129 29137
12. Goldberg JL. Barres BA. 2000 The relationship between neuronal survival and regeneration AnnuRevNeurosci 23 579 612
13. Hansen MR. Zha XM. Bok J. Green SH. 2001 Multiple distinct signal pathways, including an autocrine neurotrophic mechanism, contribute to the survival-promoting effect of depolarization on spiral ganglion neurons in vitro JNeurosci 21 2256 2267
14. Hetman M. Gozdz A. 2004 Role of extracellular signal regulated kinases 1 and 2 in neuronal survival EurJBiochem 271 2050 2055
15. Hohlfeld T. Meyer-Kirchrath J. Vogel YC. Schror K. 2000 Reduction of infarct size by selective stimulation of prostaglandin EP (3) receptors in the reperfused ischemic pig heart JMolCell Cardiol 32 285 296
16. Hunter AJ. Mackay KB. Rogers DC. 1998 To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents? Trends PharmacolSci 19 59 66
17. Jadhav V. Jabre A. Lin SZ. Lee TJ. 2004 EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries JCerebBlood Flow Metab 24 1305 1316
18. Jin K. Mao XO. Zhu Y. Greenberg DA. 2002 MEK and ERK protect hypoxic cortical neurons via phosphorylation of Bad JNeurochem 80 119 125
19. Kabashima K. Saji T. Murata T. Nagamachi M. Matsuoka T. Segi E. Tsuboi K. Sugimoto Y. Kobayashi T. Miyachi Y. Ichikawa A. Narumiya S. 2002 The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut JClinInvest 109 883 893
20. Kao HT. Song HJ. Porton B. Ming GL. Hoh J. Abraham M. Czernik AJ. Pieribone VA. Poo MM. Greengard P. 2002 A protein kinase A-dependent molecular switch in synapsins regulates neurite outgrowth NatNeurosci 5 431 437
21. Kim YS. Zhuang H. Koehler RC. Doré S. 2005 Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity Free RadicBiolMed 38 85 92
22. Kitagawa H. Warita H. Sasaki C. Zhang WR. Sakai K. Shiro Y. Mitsumoto Y. Mori T. Abe K. 1999 Immunoreactive Akt, PI3-K and ERK protein kinase expression in ischemic rat brain NeurosciLett 274 45 48
23. Lalli E. Sassone-Corsi P. 1994 Signal transduction and gene regulation: the nuclear response to cAMP JBiolChem 269 17359 17362
24. 2-mediated neuroprotection against TNF-alpha: possible involvement of multiple signal transduction and beta-catenin/T-cell factor JNeuroimmunol 155 21 31
25. 2 EP2 receptor in cerebral ischemia JNeurosci 24 257 268
26. Nakatani Y. Kitazawa T. Fujimoto M. Tamura N. Uemura M. Yamao J. Fukui H. 2004 Effect of prostaglandin E receptor subtype EP4 selective agonist on the secretion of tumor necrosis factor-alpha by macrophages in acute ethanol-loaded rats Alcohol ClinExpRes 28 123S 128S
27. Namba T. Sugimoto Y. Negishi M. Irie A. Ushikubi F. Kakizuka A. Ito S. Ichikawa A. Narumiya S. 1993 Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity Nature 365 166 170
28. Narumiya S. FitzGerald GA. 2001 Genetic and pharmacological analysis of prostanoid receptor function JClinInvest 108 25 30
29. Narumiya S. Sugimoto Y. Ushikubi F. 1999 Prostanoid receptors: structures, properties, and functions PhysiolRev 79 1193 1226
30. Nawashiro H. Martin D. Hallenbeck JM. 1997 Inhibition of tumor necrosis factor and amelioration of brain infarction in mice JCerebBlood Flow Metab 17 229 232
31. Oka T. Oka K. Saper CB. 2003 Contrasting effects of E type prostaglandin (EP) receptor agonists on core body temperature in rats Brain Res 968 256 262
32. Ollivier V. Ternisien C. Vu T. Hakim J. de Prost D. 1993 Pentoxifylline inhibits the expression of tissue factor mRNA in endotoxin-activated human monocytes FEBS Lett 322 231 234
33. Omote K. Kawamata T. Nakayama Y. Yamamoto H. Kawamata M. Namiki A. 2002 Effects of a novel selective agonist for prostaglandin receptor subtype EP4 on hyperalgesia and inflammation in monoarthritic model Anesthesiology 97 170 176
34. Perkins D. Pereira EF. Aurelian L. 2003 The herpes simplex virus type 2, R1 protein kinase (ICP10 PK) functions as a dominant regulator of apoptosis in hippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1 JVirol 77 1292 1305
35. Pober JS. Slowik MR. De Luca LG. Ritchie AJ. 1993 Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1 JImmunol 150 5114 5123
36. Riccio A. Ahn S. Davenport CM. Blendy JA. Ginty DD. 1999 Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons Science 286 2358 2361
37. Rydel RE. Greene LA. 1988 cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor ProcNatlAcadSciUSA 85 1257 1261
38. Shimoke K. Yamagishi S. Yamada M. Ikeuchi T. Hatanaka H. 1999 Inhibition of phosphatidylinositol 3-kinase activity elevates c-Jun N-terminal kinase activity in apoptosis of cultured cerebellar granule neurons Brain ResDevBrain Res 112 245 253
39. Singer CA. Figueroa-Masot XA. Batchelor RH. Dorsa DM. 1999 The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons JNeurosci 19 2455 2463
40. (STAIR-II), S.T.A.I.R.I. 2001 Recommendations for clinical trial evaluation of acute stroke therapies Stroke 32 1598 1606
41. Takadera T. Shiraishi Y. Ohyashiki T. 2004 Prostaglandin E2 induced caspase-dependent apoptosis possibly through activation of EP2 receptors in cultured hippocampal neurons NeurochemInt 45 713 719
42. Takadera T. Yumoto H. Tozuka Y. Ohyashiki T. 2002 Prostaglandin E (2) induces caspase-dependent apoptosis in rat cortical cells NeurosciLett 317 61 64
43. 2 suppresses chemokine production in human macrophages through the EP4 receptor JBiolChem 277 44147 44154
44. Xiao CY. Yuhki K. Hara A. Fujino T. Kuriyama S. Yamada T. Takayama K. Takahata O. Karibe H. Taniguchi T. Narumiya S. Ushikubi F. 2004 Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4 Circulation 109 2462 2468
45. Zacharowski K. Olbrich A. Thiemermann C. 1999 Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of K (ATP)-channels EurJPharmacol 367 33 39
46. Zhu Y. Culmsee C. Klumpp S. Krieglstein J. 2004 Neuroprotection by transforming growth factor-beta1 involves activation of nuclear factor-kappaB through phosphatidylinositol-3-OH kinase/Akt and mitogen-activated protein kinase-extracellular-signal regulated kinase1,2 signaling pathways Neuroscience 123 897 906
47. Zhu H. Wang Z. Ma C. Tian J. Fu F. Li C. Guo D. Roeder E. Liu K. 2003 Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies Planta Med 69 429 433